Phase 3
N=1,281
Rapid HIV Testing and Counseling in Drug Abuse Treatment
Substance-Related Disorders
Bottom Line
View on ClinicalTrials.gov: NCT00809445 ↗Enrolled (actual)
1,281
Serious AEs
0.5%
Results posted
Sep 2014
Primary outcome: Primary: Self-Report Receipt of HIV Test Results — 78; 338; 347 participants — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- On-site HIV rapid test and brief, prevention counseling (Behavioral); On- site HIV rapid test & information (Behavioral); Referral for off-site HIV testing (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Miami
- Primary completion
- Dec 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Self-Report Receipt of HIV Test Results |
78; 338; 347 | <0.001 sig |
| PRIMARY Number of Risky Sexual Behaviors |
20.5; 21.3; 21.3 | 0.39 |
| SECONDARY Sharing of Needles Used in Drug Use |
17; 32; 24; 2; 1; 6 | 0.044 sig |
| SECONDARY Self-Report of Ever Having Been Tested |
103; 344; 352 | <0.0001 sig |
Summary
This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV risk behaviors.
Eligibility Criteria
Inclusion Criteria
- At least 18 years of age
- HIV-negative or HIV status unknown
- No receipt of results from HIV test initiated within last 12 months
- Be able to communicate in English
Data sourced from ClinicalTrials.gov (NCT00809445). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.